UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

Cell metabolism, 2017-10, Vol.26 (4), p.633-647.e7

2017

Volltextzugriff (PDF)

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

Nature communications, 2019-03, Vol.10 (1), p.1373-1373, Article 1373

2019

Volltextzugriff (PDF)

Activation of MAPK Pathways due to DUSP4 Loss Promotes Cancer Stem Cell-like Phenotypes in Basal-like Breast Cancer

Cancer research (Chicago, Ill.), 2013-10, Vol.73 (20), p.6346-6358

2013

Volltextzugriff (PDF)

Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER + Breast Cancer

Clinical cancer research, 2017-10, Vol.23 (20), p.6138-6150

2017

Volltextzugriff (PDF)

Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence

Science translational medicine, 2016-04, Vol.8 (334), p.334ra53

2016

Volltextzugriff (PDF)

Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors

Frontiers in oncology, 2021-10, Vol.11, p.752918-752918

2021

Volltextzugriff (PDF)

The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

eLife, 2016-07, Vol.5

2016

Volltextzugriff (PDF)

Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER + /HER2 + Breast Cancers: Implications to the ExteNET Trial

Clinical cancer research, 2019-01, Vol.25 (2), p.771-783

2019

Volltextzugriff (PDF)

An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression

JNCI : Journal of the National Cancer Institute, 2017-11, Vol.109 (11)

2017

Volltextzugriff (PDF)

ER + Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

Clinical cancer research, 2018-06, Vol.24 (11), p.2517-2529

2018

Volltextzugriff (PDF)

Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer

Clinical Medicine Insights. Oncology, 2019, Vol.13, p.1179554919868482-1179554919868482

2019

Volltextzugriff (PDF)

LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer

The Journal of clinical investigation, 2014-12, Vol.124 (12), p.5490-5502

2014

Volltextzugriff (PDF)

Correction: Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER + Breast Cancer

Clinical cancer research, 2019-02, Vol.25 (4), p.1433-1433

2019

Volltextzugriff (PDF)

Correction: ER + Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

Clinical cancer research, 2019-02, Vol.25 (4), p.1431-1431

2019

Volltextzugriff (PDF)

A nationwide pilot study on breast cancer screening in Peru

Ecancermedicalscience, 2023-01, Vol.17, p.1494-1494

2023

Volltextzugriff (PDF)

Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America

Ecancermedicalscience, 2019-01, Vol.13, p.896-896

2019

Volltextzugriff (PDF)

Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

eLife, 2019-01, Vol.8

2019

Volltextzugriff (PDF)

Maybe we don't know JAK?

Molecular & cellular oncology, 2016-07, Vol.3 (4), p.e1192713-e1192713

2016

Volltextzugriff (PDF)

Safety of immunotherapy in Peruvian patients with diverse type of malignancies: Experience at a private center

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19258-e19258

2020

Volltextzugriff (PDF)

Patterns of mutation enrichment in metastatic triple-negative breast cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e12596-e12596

2019

Volltextzugriff (PDF)

Abstract 4818: Neratinib/fulvestrant but not fulvestrant alone maintain complete responses after treatment with trastuzumab/paclitaxel of mice bearing ER+/HER2+ xenografts

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4818-4818

2017

Volltextzugriff (PDF)

Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer

Clinical breast cancer, 2021-06, Vol.21 (3), p.239-246.e4

2021

Volltextzugriff (PDF)

Abstract 1518: Gene expression profile and gender differences related with immune processes in solid tumors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1518-1518

2019

Volltextzugriff (PDF)

Impact of liquid-biopsy in the therapeutic decision making process in a Peruvian institution

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18761-e18761

2018

Volltextzugriff (PDF)

1 – 25 von 326

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(280)
Mit Volltextzugriff
(274)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

Activation of MAPK Pathways due to DUSP4 Loss Promotes Cancer Stem Cell-like Phenotypes in Basal-like Breast Cancer

Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER + Breast Cancer

Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence

Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors

The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER + /HER2 + Breast Cancers: Implications to the ExteNET Trial

An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression

ER + Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer

LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer

Correction: Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER + Breast Cancer

Correction: ER + Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

A nationwide pilot study on breast cancer screening in Peru

Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America

Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

Maybe we don't know JAK?

Safety of immunotherapy in Peruvian patients with diverse type of malignancies: Experience at a private center

Patterns of mutation enrichment in metastatic triple-negative breast cancer

Abstract 4818: Neratinib/fulvestrant but not fulvestrant alone maintain complete responses after treatment with trastuzumab/paclitaxel of mice bearing ER+/HER2+ xenografts

Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer

Abstract 1518: Gene expression profile and gender differences related with immune processes in solid tumors

Impact of liquid-biopsy in the therapeutic decision making process in a Peruvian institution

Suchergebnisse filtern